🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Matthew Lindsley

National Institutes of Health

ORCID: 0000-0003-2358-2245

Also affiliated with National Cancer Institute, Center for Cancer Research

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Data from Phase I Study of Zotiraciclib in Combination with Temozolomide for Patients with Recurrent High-grade Astrocytomas

(2023)10.1158/1078-0432.c.6530789
Top 100%
0DataRank
Top 100%0 citations

Ying Yuan, Debra A. Long Priel, Danielle Fink, Cody J. Peer, Tristan M. Sissung +30 more

Papers

Driven by 8 papers — median percentile 0. Top paper: “Elevated IL-13 in effusions of patients with HIV and primary effusion lymphoma as compared with other Kaposi sarcoma herpesvirus-associated disorders”.

Elevated IL-13 in effusions of patients with HIV and primary effusion lymphoma as compared with other Kaposi sarcoma herpesvirus-associated disorders

AIDS(2020)10.1097/qad.0000000000002692
N/A
0DataRank · unranked
10 citations

Kathryn Lurain, Vickie Marshall, Adam Rupert, Nazzarena Labò, Elena Cornejo-Castro +12 more

Phase I Study of Zotiraciclib in Combination with Temozolomide for Patients with Recurrent High-grade Astrocytomas

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4730
N/A
0DataRank · unranked
60 citations

Ying Yuan, Debra A. Long Priel, Danielle Fink, Cody J. Peer, Tristan M. Sissung +30 more

The Montreal Cognitive Assessment (MoCA) in neuro-oncology: A pilot study of feasibility and utility in telehealth and in-person clinical assessments

Neuro-Oncology Practice(2022)10.1093/nop/npac038
N/A
0DataRank · unranked
12 citations

James L. Rogers, Elizabeth Vera, Alexa Christ, Heather Leeper, Alvina Acquaye +20 more

Evaluation of the key geriatric assessment constructs in primary brain tumor population - a descriptive study

Journal of Geriatric Oncology(2022)10.1016/j.jgo.2022.08.013
N/A
0DataRank · unranked
1 citations

Elizabeth Vera, Anna Choi, Alvina Acquaye, Nicole Briceno, Alexa Christ +21 more

Association of Employment Status With Symptom Burden and Health-Related Quality of Life in People Living With Primary CNS Tumors

Neurology(2023)10.1212/wnl.0000000000207082
N/A
0DataRank · unranked
16 citations

Elizabeth Vera, Alexa Christ, Alvina Acquaye, Nicole Briceno, Anna Choi +20 more

Data from Phase I Study of Zotiraciclib in Combination with Temozolomide for Patients with Recurrent High-grade Astrocytomas

(2023)10.1158/1078-0432.c.6530789
Top 100%
0DataRank
Top 100%0 citations

Ying Yuan, Debra A. Long Priel, Danielle Fink, Cody J. Peer, Tristan M. Sissung +30 more

Data from Phase I Study of Zotiraciclib in Combination with Temozolomide for Patients with Recurrent High-grade Astrocytomas

(2023)10.1158/1078-0432.c.6530789.v1
Top 100%
0DataRank
Top 100%0 citations

Ying Yuan, Debra A. Long Priel, Danielle Fink, Cody J. Peer, Tristan M. Sissung +30 more

Long-term survivors of glioblastoma: Tumor molecular, clinical, and imaging findings

Neuro-Oncology Advances(2024)10.1093/noajnl/vdae019
N/A
0DataRank · unranked
13 citations

Elizabeth Vera, Edina Komlódi-Pásztor, Zied Abdullaev, Anna Choi, Ewa Grajkowska +21 more